Add Johnson & Johnson to the list of biopharma giants that have struck most-favored-nation (MFN) drug pricing deals with the Trump administration. With the agreement—which frees J&J up from tariffs on ...

Wrestling insider Sean Ross Sapp has suggested there is a “significant chance” AAA stars could appear in WWE 2K26. That possibility now seems more likely following the addition of AAA wrestlers to ...

The J.J. McCarthy experiment has not gone as the Vikings hoped. Minnesota traded up one spot in the first round of the 2024 NFL draft to take the national championship-winning quarterback out of ...

KNOXVILLE, Tenn. (WATE) — Tennessee football has hired Andrew “A.J.” Jackson as their new LEOs coach. Jackson comes to Rocky Top with 13 years of defensive line coaching experience. Most recently, ...

Mr Jones Watches has relaunched one of its popular limited edition watches. This time, it's a part of the permanent collection, too. After seeing swathes of fantastic watches launched in 2025, it's ...

Phillies re-signed Kyle Schwarber, considering bringing back veteran catcher J.T. Realmuto. Report highlights urgency to retain Realmuto, with few better alternatives available. Phillies added another ...

The Minnesota Vikings needed another quarterback this week. J.J. McCarthy has been ruled out for Week 17 with an injury to his right hand. Max Brosmer will start on Thursday, Christmas Day, against ...

AI companies are continuing to pour ungodly amounts of money into building out data centers, in an enormous bet that both analysts and tech leaders warn may not pay off for many years to come — if it ...

Math scores in the U.S. have been so bad for so long that teachers could be forgiven for trying anything to improve them. Unfortunately, many of the strategies they’re using could be making things ...

C.J. Gardner-Johnson has always been known as a pain to opposing offenses but in Sunday's 24-20 Bears win he literally was a pain to the Giants and Jaxson Dart. CHICAGO — It's amazing, really. Only ...

Nov 6 (Reuters) - The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's (JNJ.N), opens new tab drug Caplyta as an add-on treatment for adults with major depressive ...